Research in the News
DOR researchers are recognized internationally for their scientific expertise and have contributed more than 3,000 scientific papers about how to use health informatics, manage chronic illness, and motivate self-care and disease prevention.
Teens, Parents, Physicians Support Screening Young People for Gender Identity, Study Suggests
Kaiser Permanente physician researchers say screening could improve care for gender diverse adolescents.
Could Heart Drug Reduce COVID-19 Risk?
Kaiser Permanente researchers are studying whether icosapent ethyl, an omega-3 fatty acid used to prevent heart attacks and strokes, can be used to prevent or reduce the risk of COVID-19.
Fewer Endometrial Cancer Diagnoses During COVID-19 Pandemic
New Kaiser Permanente study one of first to show novel coronavirus impact on cancer detection.
Early Colorectal Cancer Screening Benefits African Americans
Kaiser Permanente study supports starting screening at age 45 among this higher-risk population.
Kaiser Permanente Researchers Develop New Prostate Cancer Risk Calculator
Shared decision-making tool provides information that can help patients during prostate cancer screening.
Kaiser Permanente Researchers Present Latest Findings at Global AIDS2020 Conference Held Online
Kaiser Permanente’s rich history of research and care delivery innovation around HIV and AIDS is being highlighted at the global International AIDS Conference (AIDS2020).
On-demand HIV Prevention Pills Worked Well for San Francisco Patients
New as-needed PrEP regimen may increase use of highly effective medication, Kaiser Permanente researchers say.
Fewer Heart Attack Patients Seen During COVID-19 Pandemic
Weekly number of patients admitted to Kaiser Permanente Northern California (KPNC) hospitals with acute myocardial infarction (heart attacks) after the onset of the COVID-19 pandemic fell to nearly half.
COVID-19 Pandemic Brings Telehealth Center Stage for Oncologists and Their Patients
A new research paper explains how Kaiser Permanente Northern California (KPNC) quickly ramped up its existing telehealth oncology program at the onset of the COVID-19 pandemic.